Point72 Asset Management, L.P.
Position in CTMX — CytomX Therapeutics, Inc.
CIK 1603466
STAMFORD, CT
Position in CTMX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,291,373
-$7,722,960 QoQ
Shares Held
7,811,033
-0.8% QoQ
Ownership
3.58%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#8
of 178 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. CTMX ranks #23 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in CTMX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,291,373 | 7,811,033 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $29,291,373 | 7,811,033 | Shares | Sole | 2026-08-14 | |
| 2026-04-15 | $49,542,489 | 10,864,581 | Shares | Sole | 2026-04-16 | |
| 2026-03-31 | $37,014,333 | 7,875,390 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,107,431 | 5,189,538 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $12,978,754 | 4,068,575 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $18,352,094 | 8,084,623 | Shares | Defined | 2025-08-14 | |
| 2025-05-12 | $27,891,072 | 13,094,400 | Shares | Sole | 2025-05-14 | |
| 2025-03-31 | $1,685,400 | 2,650,000 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $2,729,500 | 2,650,000 | Shares | Defined | 2025-02-14 | |
| 2022-06-30 | $5,032,500 | 2,750,000 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $11,671,371 | 4,371,300 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,292,098 | 6,303,025 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $32,082,397 | 6,303,025 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $40,473,387 | 6,393,900 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $48,969,550 | 6,335,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $818,750 | 125,000 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $8,608,271 | 1,033,406 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,661,045 | 216,564 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||